NewEdge Advisors, LLC

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1633516 NEW ORLEANS, LA

Position in BCRX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$530,990

+$478,664 QoQ

Shares Held

53,099

+1.5% QoQ

Ownership

0.021%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#159

of 316 holders

Holding Since

Sep 2020

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

NewEdge Advisors, LLC holds $12,323,215 across 27 Drug Manufacturers - Specialty & Generic names. BCRX ranks #9 (4.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	36,078	$2,592,565
2	NBIX	Neurocrine Biosciences Inc	12,619	$2,126,806
3	UTHR	UNITED THERAPEUTICS Corp	3,861	$2,092,005
4	TEVA	Teva Pharmaceutical Industries Ltd	37,994	$1,287,236
5	HLN	Haleon plc	133,508	$1,245,629
6	HIMS	Hims & Hers Health, Inc.	21,721	$753,067
7	VTRS	Viatris Inc	39,976	$634,818
8	COLL	Collegium Pharmaceutical, Inc	16,739	$605,951

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$530,990	53,099	+1.5%	Shares	Sole	2026-08-12
2026-03-31	$52,326	52,326	+4.6%	Shares	Sole	2026-05-18
2025-12-31	$390,319	50,041	+454818.2%	Shares	Sole	2026-02-18
2025-03-31	$82	11	0.0%	Shares	Sole	2025-05-15
2024-12-31	$82	11	-63.3%	Shares	Sole	2025-02-13
2023-09-30	$212	30	0.0%	Shares	Sole	2023-11-14
2023-06-30	$211	30	-99.3%	Shares	Sole	2023-08-14
2023-03-31	$34,260	4,108	-50.7%	Shares	Sole	2023-05-12
2022-12-31	$95,571	8,325	-27.6%	Shares	Sole	2023-02-14
2022-03-31	$186,908	11,495	-8.9%	Shares	Sole	2022-05-13
2021-12-31	$174,759	12,618	-11.5%	Shares	Sole	2022-02-17
2021-09-30	$204,844	14,255	+16.0%	Shares	Sole	2021-10-29
2021-06-30	$194,320	12,291	-0.9%	Shares	Sole	2021-07-22
2021-03-31	$126,169	12,406	-48.3%	Shares	Sole	2021-04-26
2020-09-30	$82,560	24,000	—	Shares	Sole	2020-11-03
No filing history on record for this holder in this stock.